Left ventricular (LV) diastolic dysfunction, due to increased diastolic stiffness and elevated filling pressures, has been suggested to occur before global systolic function is depressed in AS patients. (8) Reversal of diastolic dysfunction after SAVR is a slow process (years), which is why preoperative diastolic dysfunction has been proposed as a marker of postoperative irreversible LV dysfunction. (9, 10) Immediate improvement in LV diastolic function has been demonstrated after TAVI but long term potential recovery in LV diastolic function remains unexplored. (11) The transapical approach is considered to be more invasive since it involves LV puncture but it requires less catheter manipulation within the aortic arch. Furthermore, as a consequence of using transfemoral approach as default choice of intervention in patients accepted to TAVI TA patients have been suggested to have a higher risk profile due to higher frequency of comorbidities such as coronary artery disease or renal failure. (2, 12) It is unknown whether patients undergoing transapical and transfemoral approaches differ in postprocedural recovery of LVF. Impaired longitudinal right ventricular function (RVF) after SAVR is common. (13) However, in a previous study we showed an early recovery in longitudinal RVF after TAVI.(6) Presently there is no knowledge about midterm RVF after TAVI.
The aim of this study was to 1) evaluate early and midterm changes in systolic and diastolic LVF in patients with severe AS undergoing TAVI, including both the transfemoral and transapical
Patients
The study design was prospective repeated cross sectional. From September 2008 to June 2011, 68 patients with severe AS underwent TAVI at our center. All patients were assessed by a multidisciplinary team not to be candidates for surgery due to high risk or contraindications to SAVR. Exclusion criteria were: an aortic annulus diameter smaller than 18 mm or larger than 25 mm (when a 29 mm prosthesis became available 27 mm was used as the upper limit) or survival with a reasonable quality of life or duration was unlikely. Preprocedural investigations included transthoracic and transesophageal echocardiography, coronary angiography, iliofemoral angiography and CT scan of the aorta with 3D reconstruction. The default approach was transfemoral with transapical as a second choice.
Eight patients were excluded due to the following reasons: administrative error (n=3), refusal to take part in follow up at our center (n=3), poor echocardiographic image quality (n=1), chordal rupture during the TAVI procedure with severe mitral regurgitation (n=1). The patients who refused follow up had a good clinical status, normal LVF and aortic valve function reported by their local cardiologist.
The final study population consisted of 60 patients, who were prospectively investigated using echocardiography one day preprocedurally, as well as 7 weeks and 6 months after TAVI (study flow chart presented in fig. 1 ).
Twenty-seven AS patients, referred for SAVR, could be matched to 27 TAVI patients in terms of gender, age (±10 years), and LVF (normal/slightly reduced ejection fraction or moderately/severely reduced ejection fraction).
Echocardiography
All patients were examined by echocardiography (Vivid 7 ultrasound system, GE Vingmed Ultrasound, Norway) with off-line image analysis. Parameters were measured according to the appropriate guidelines. (14, 15) 
Longitudinal LVF and RVF
To estimate regional myocardial function, peak systolic velocity (PSV) was measured in the LV septal Impaired relaxation was defined as E/A ratio <0.8, DT >200ms, IVRT ≥100ms, S>D, é <8cm/s, and E/é ratio <8. Pseudonormal filling was defined as E/A ratio 0.8-1.5, S<D, é <8cm/s and E/é ratio 9-12.
Restrictive filling was defined as E/A ≥2.0, DT <160ms, S/D<1.0, IVRT ≤60ms and E/é ratio >13.
Patients with atrial fibrillation formed a fifth group. SAVR was performed through full sternotomy and with cardiopulmonary bypass. Twelve patients underwent simultaneous coronary-aortic-bypass grafting (CABG).
Statistics
Continuous variables are expressed as mean±SD and categorical variables as numbers or percentages.
Analysis of variance for repeated measurement was used to assess differences between the preoperative, 7 week and 6 month data, followed by the 
Results
Under each subheading data are presented in the following order: first all TAVI patients followed by transapical and transfemoral treatment separately analyzed and finally, comparison of the matched TAVI and SAVR is presented.
Clinical and Valve Function Data
Clinical characteristics are presented in AR of trivial or mild grade was detected in 88 and 81% of the patients at the 7 week and 6 month follow ups, respectively and was mainly paravalvular. No TAVI patient had more than mild AR early postprocedurally, while this was found in 2 patients at 6 months. Nine patients with MR graded as more than mild preoperatively showed a significant decrease at the 6 month follow up (p=0.011).
Prior to SAVR, AVAI was 0.35±0.09 cm 2 /m 2 and mean aortic pressure gradient 51±16 mmHg. Both AVAI and mean aortic pressure gradient were stable between the two follow ups (0.68±0.17 vs.
0.68±0.15 cm 2 /m 2 , p=1.0; 13±3 vs. 14±4 mmHg, p=0.6).
Left Ventricular Function

Global LV function
At the following time points: preoperatively, 7 weeks and 6 months postprocedurally, 79, 74 and 85%, respectively, of the TAVI patients had normal global LVF. In the transapical and transfemoral groups postprocedurally (see table 3 in supporting information).
In the matched TAVI and SAVR groups, 80 and 92 % of the patients had normal global LVF preoperatively. Postprocedurally, no significant change could be seen.
LV dimensions and mass
In all TAVI patients, LV end diastolic and end systolic dimensions and posterior wall thickness were unchanged at the two follow ups, while a significant decrease of septal thickness was observed at the early follow up and a trend towards a further decrease at the second follow up (13±3 The transapical group had unchanged longitudinal function at the two postoperative visits (Fig. 2, all p>0.05), while patients in the transfemoral group increased their longitudinal function in both the septal (AVPD S p=0.003, and PSV S p<.001) and lateral walls (AVPD L p=0.023 and PSV L p=0.001) early postprocedurally. This was unchanged between the two follow up visits.
Preoperatively, the SAVR group had higher AVPD S and PSV S than the matched TAVI group did.
Postoperatively, the SAVR group had improved AVPD L and PSV L , while the septal wall remained unchanged (Fig. 3) . The difference in LV septal long axis function between the two matched groups was reduced at the early follow up, and SAVR had superior lateral LVF.
LV diastolic function
The improvement seen among TAVI patients between the preoperative and 6 month postoperative examinations was mainly due to more frequent normal diastolic function and fewer patients with a pseudonormal filling pattern (Fig. 4) . The early increase of é-septal and é-lateral was, at 6 months, only seen in the septal LV wall (Table II) . Six months postoperatively, E/é-septal, but not E/é-lateral, had decreased. When analyzing the TAVI patients grouped after previously published reference values for é-septal, é-lateral, E/é-septal and E/é-lateral, only patients with preprocedural abnormal é or E/é showed improvement (Fig. 5) . (17) When analyzing the two TAVI approaches separately, the patients in the transfemoral group showed improved diastolic function after the intervention, while patients in the transapical group did not (Fig.   4 ). É and E/é did not change significantly in the transapical group, while transfemoral patients had an increased é-septal and é-lateral, and decreased E/é-septal postprocedurally (Table II) .
The SAVR group did not improve diastolic function class significantly postoperatively, but é-lateral increased and E/é-lateral diminished (Table II) . At all examinations the SAVR group had better LV diastolic function class than the matched TAVI group (Fig. 4 , all p<0.01). Preoperatively, SAVR patients had higher é-lateral and lower E/é-septal, while postoperative differences between the two matched groups were only seen in the lateral wall.
Longitudinal RVF
Seven weeks after TAVI, PSV RV increased from 9±3 to 11±3 cm/s (p=0.001), while AVPD RV was unchanged (16±5 vs. 16±5, p=ns). Neither PSV nor AVPD displayed a significant change between the early and late follow up. The transfemoral and transapical groups had unchanged AVPD RV postprocedurally while the transfemoral group improved PSV RV early postprocedurally (p=0.004, fig. 
2)
Although the matched SAVR group had better longitudinal RV function than the TAVI patients preoperatively, this difference was markedly reduced postoperatively and was even lower than in TAVI patients when examined by PSV (Fig. 3) . At the 6 month follow up, a significant but incomplete recovery of AVPD RV was observed in the SAVR group (p=0.009).
Discussion
This is the first prospective study to explore regional LVF and RVF in patients undergoing TAVI by the transapical or transfemoral approach with a matched SAVR cohort. Our main findings were 1) patients undergoing TAVI had improved longitudinal LVF 7 weeks and 6 months after the procedure;
2) when analyzed separately, this was due to an improved postprocedural longitudinal LV systolic function among transfemoral patients; 3) LV diastolic function improved six months after TAVI; 4)
longitudinal RVF was preserved after TAVI while being markedly decreased in patients undergoing SAVR.
Longitudinal LV function and aortic valve intervention
Longitudinal LVF is depressed early in AS patients despite a normal LVEF. This holds for both asymptomatic and symptomatic patients and provides prognostic information regarding the risk of future symptoms, need of SAVR, or death. (3, 19) The early involvement of long axis variables has been proposed to be due to the vulnerability of the subendocardial fibers to ischemia associated with LV hypertrophy and to wall stress due to increased afterload.(3) Immediately and one week after aortic valve intervention, an increase in PSV and AVPD has been found before changes in LV mass were detected.(5,7) This very early improvement in longitudinal LVF without a decrease of LV mass has been proposed to be due to the immediate afterload reduction. Seven weeks after intervention, we could confirm an improvement in longitudinal LVF after TAVI with a concurrent decrease in LV mass, indicating that myocardial remodeling also contributes to these early changes in longitudinal function. Moreover, we could also show that this improvement in regional function, as seen in the present study was stable up until at least six months after TAVI.
Transapical patients did not increase their longitudinal LVF after TAVI. This could be due to irreversible LV dysfunction caused by long standing AS or coronary artery disease. In contrast to our findings, a group of transapical patients displayed a modest increase in longitudinal LVF 6 weeks after TAVI. (20) That center did not have access to the transfemoral approach as an alternative, which could indicate that the absent increase of longitudinal function we found in the transapical group was due to our selection process where the transfemoral approach was the first choice. This is further supported by the difference in clinical characteristics between the two groups where the transapical group appeared as a subgroup with more severe co-morbidities. However, in the present study we cannot rule out a possible influence on cardiac motion or myocardial damage caused by surgical opening of the pericardium as part of transapical TAVI.
Prior to intervention, there was no difference in AVPD L and PSV L between SAVR and TAVI, while after surgery the lateral longitudinal LVF was significantly higher in SAVR than TAVI patients. On the other hand, the initial significant difference between these groups in septal longitudinal function diminished after intervention. These regional differences could probably be explained by the paradoxical septal motion, frequently occurring after open heart surgery. (21) LV diastolic function and aortic stenosis LV diastolic dysfunction is observed in AS patients before impairment of global systolic LVF.
Awareness of the importance to assess diastolic function in the natural history of AS has increased during recent years. (4, 8, 19) We found an improvement in diastolic functional class in patients undergoing TAVI, 6 months after intervention. Wall velocity (é) increased early after TAVI, which could be interpreted in terms of an improvement in myocardial relaxation. E/é has previously been proposed to be a useful marker of LV filling pressures in AS patients. In the present study, E/e´ decreased at 6 months, which suggests a reduction in filling pressure. (4, 22) Furthermore, we could
show that patients with indirect signs of disturbed LV relaxation or increased LV filling pressure estimated as é and E/é before TAVI improved early after the procedure. Nevertheless, this patient category continued to have lower é and higher E/é than patients with preprocedural values within the normal range. These measures may thus identify patients at risk of irreversible LV dysfunction.
Patients accepted to SAVR had better LV diastolic function both before and after surgery, according to the classification, than the matched TAVI patients did. However, when using TDI, differences in the response of the lateral and septal LV wall to the aortic valve intervention could be observed. These regional differences in diastolic function could be related to the paradoxical septal motion seen after cardiothoracic surgery but not after catheter intervention. (6, 21) Findings of an increase in é in the lateral but not the septal LV wall after SAVR have been published earlier. (7) Longitudinal Right Ventricular Function and Aortic Valve Surgery
Depressed longitudinal RVF and abnormal septal motion after open heart surgery are known phenomena, although the exact mechanism is unclear. (7, 13, 21) We have, consistent with a previous report, shown that while SAVR decreases PSV and AVPD in the RV free wall, TAVI patients display either preserved or increased longitudinal function early after TAVI. (6, 20, 23) In this study we could, for the first time, show that this initial change in RV function after TAVI was stable 6 months later.
Since longitudinal RVF closely correlates with RVEF, PSV and AVPD in the free wall are often used to evaluate RVF. (24, 25) Although 3D echocardiographic studies have found that the overall RVF is not depressed after open heart surgery, depressed longitudinal RVF must be taken into consideration when evaluating postoperative patients.(26) TAVI seems to leave longitudinal RVF unaffected, which is an important finding in an era of less invasive cardiac intervention.
Limitations
The study is limited by a relatively small sample size which precluded further subgroup analysis of longitudinal LVF in patients with atrial fibrillation or coronary artery disease. There were preprocedural differences in LVF and clinical characteristics between patients undergoing transfemoral or transapical TAVI which potentially could have had impact on postprocedural myocardial function. This could, at least partly, be explained by the selection process where the transfemoral approach was preferred when possible. Still however, the main aim of the study was to investigate potential changes in regional myocardial function after the two approaches and this could be appropriately analyzed by the used statistical methods. Although the SAVR patient cohort was matched to TAVI patients according to age, gender and LVF, the results should be interpreted with caution due to other essential unmatched differences in preinterventional clinical characteristics.
Pulsed TDI is clinically available and has shown satisfying reproducibility. However the technique is limited by the angle dependency and the possibility that velocities recorded are influenced by global heart motion.
Conclusion
Our data suggest that the early improvement in longitudinal LVF after TAVI is stable 6 months postprocedurally. Moreover, there is a considerable difference in the response of longitudinal LV and RV function between patients assigned to either the transapical or the transfemoral aortic valve implantation approach. Transapical patients have been suggested to represent a patient population with higher surgical risk and we demonstrate that longitudinal LV and RV function did not improve significantly after transapical aortic valve implantation, suggesting irreversible ventricular dysfunction in this patient category. Yet, we cannot rule out that the differences between the approaches are procedure related.
Furthermore, the current study shows that TAVI avoids the reduction in longitudinal RVF frequently seen after SAVR. This could have a clinical impact for those patients with preoperative lowered RV function. Further studies are needed to examine if that patient category is favored by less invasive interventional approaches.
Legends Figure 1
Study flow chart. TA; transapical, TF; transfemoral, mTAVI; matched TAVI. preoperatively are excluded. TAVI-patients who died during follow up had preoperatively impaired relaxation (n=1), pseudonormal pattern (n=1), restrictive pattern (n=1) and atrial fibrillation (n=3). TAVI vs SAVR: **p<0.01 
